Mammoth Biosciences is a biotechnology company focused on CRISPR-based technologies.
About
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for life-threatening diseases. They also develop CRISPR-based diagnostics and have a platform that uses novel CRISPR-Cas enzymes for gene editing and molecular detection.
Tags
Total Employees
164
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Mammoth Biosciences do?
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for life-threatening diseases. They also develop CRISPR-based diagnostics and have a platform that uses novel CRISPR-Cas enzymes for gene editing and molecular detection.
How much funding has Mammoth Biosciences raised?
Mammoth Biosciences has raised a total of $235M in funding. The most recent round on record is Other Equity.
When was Mammoth Biosciences founded?
Mammoth Biosciences was founded in 2017.
How many employees does Mammoth Biosciences have?
Mammoth Biosciences has approximately 164 people on record.